FRI0372 The ducas: proposal for a digital ulcer assessment score in scleroderma

Cosimo Bruni(University of Florence), Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), Tanaka Ngcozana(University College London), Silvia Bellando-Randone(Azienda Ospedaliero-Universitaria Careggi), Jonathan Grotts, Francesca Braschi(University of Florence), CP Denton(The Royal Free Hospital), Y.A.S. Suliman(Assiut University), D.E. Furst(University of California, Los Angeles), Serena Guiducci(Azienda Ospedaliero-Universitaria Careggi)
Annals of the Rheumatic Diseases
June 1, 2017
10.1136/annrheumdis-2017-eular.5735
Cited by 1

Related Papers

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
|Annals of the Rheumatic Diseases|2009|615
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432